Author, Subjects, Keywords

Cited Author

 

 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » Malaysian Journals
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Evaluation of Polymerase Chain Reaction (PCR) Method and Hybrid Capture II (HCII) Assay for the Detection of Human Papillomavirus in Cervical Scrapings

Saini R., and Shen, T.H., and Othman N.H., and Santhanam, J., and Othman, N., and Tang, T.H., (2007) Evaluation of Polymerase Chain Reaction (PCR) Method and Hybrid Capture II (HCII) Assay for the Detection of Human Papillomavirus in Cervical Scrapings. Medical Journal of Malaysia, 62 (3). pp. 206-209. ISSN 0300-5283

Full text not available from this repository.

Affiliations

Universiti Sains Malaysia. Health Campus. School of Dental Sciences.
Universiti Sains Malaysia. Health Campus. Dept. of Pathology.
Universiti Sains Malaysia. Health Campus. Dept. of Pathology.
Universiti Sains Malaysia. Health Campus. Institute for Research in Molecular Medicine (INFORMM).
Universiti Sains Malaysia. Health Campus. Dept. of Pathology.
Universiti Kebangsaan Malaysia. Institute of Allied Health Sciences. Dept. of Biomedical Sciences.

Abstract

In order to investigate the reliability of detecting HPV DNA in cervical smears, we compared the performance of nested MY/GP PCR and FDA approved-Hybrid Capture II (HCII) using clinical cervical scrapings from 40 patients. It was found that PCR was more sensitive (81.8%) in comparison to HCII (36.4%) in detecting HPV although specificity of HCII was much higher (96.6%) than PCR (58.6%). The Negative Predictive Value (NPV) of both the techniques were quite similar but Positive Predictive Value (PPV) of HCII was much higher (80.0%) compared to PCR (42.9%). While the HCII method showed good specificity for HPV detection, its lack of sensitivity as compared to PCR may be a drawback for diagnostic use.

Item Type:Journal
Additional Information:We would like to acknowledge Prof E.M. deVilliers of DKFZ, Heidelberg, Germany for providing us the clones of HPV 6, 11, 16, 18 that were used as positive controls in this study.
Keywords:PCR, Hybrid Capture II, HPV
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:5630

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 827-41.

2. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000; 19: 1-5.

3. Walboomers JM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.

4. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am Epidemiol 1995; 141: 680-89.

5. Guerrero E, Daniel RW, Bosch FX et al. Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer. J Clin Microbiol 1992; 30: 2951-59.

6. Schiffman MH, Bauer HM, Lorincz AT et al. Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA. J Clin Microbiol 1991; 29: 573-77.

7. Kado S, Kawamata Y, Shino Y et al. Detection of human papillomaviruses in cervical neoplasias using multiple sets of generic polymerase chain reaction primers. Gynecol Oncol 2001; 81: 47-52.

8. Manos MM TY, Wright DK, Lewis AJ, Broker TR, Wolinski SM. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7/Cold Springs Harbor Laboratory 1989: 209-14.

9. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3’ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995; 76 (Pt 4): 1057-62.

10. Evander M, Edlund K, Boden E et al. Comparison of a one-step and a two-step polymerase chain reaction with degenerate general primers in a population-based study of human papillomavirus infection in young Swedish women. J Clin Microbiol 1992; 30: 987-92.

11. Harwood CA, Spink PJ, Surentheran T et al. Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J Clin Microbiol 1999; 37: 3545-55.

12. Jenkins D. Diagnosing human papillomaviruses: recent advances. Curr Opin Infect Dis 2001; 14: 53-62.

13. Cuzick J, Szarewski A, Terry G et al. Human papillomavirus testing in primary cervical screening. Lancet 1995; 345: 1533-36.

14. Giovannelli L, Lama A, Capra G et al. Detection of human papillomavirus DNA in cervical samples: analysis of the new PGMY-PCR compared to the hybrid capture II and MY-PCR assays and a two-step nested PCR assay. Clin Microbiol 2004; 42: 3861-64.

15. Bozzetti M, Nonnenmacher B, Mielzinska II et al. Comparison between hybrid capture II and polymerase chain reaction results among women at low risk for cervical cancer. Ann Epidemiol 2000; 10: 466.

16. Nonogaki S. Wakamatsu A, Longatto Filho A et al. Hybrid capture II and polymerase chain reaction for identifying HPV infections in samples collected in a new collection medium: a comparison. Acta Cytol 2004; 48: 514-20.

17. Chatterjee R, Mandal B, Bandyopadhyay S. Detection of HPV DNA in cervical carcinomas by PCR and hybrid capture assay. Indian J Pathol Microbiol 2003; 46: 596-99.

18. Soderlund-Strand A, Rymark P, Andersson P, Dillner J, Dillner L. Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia. J Clin Microbiol 2005; 43: 3260-66.

19. Federschneider JM, Yuan L, Brodsky J et al. The borderline or weakly positive Hybrid Capture II HPV test: a statistical and comparative (PCR) analysis. Am J Obstet Gynecol 2004; 191: 757-61.

Repository Staff Only: item control page